LensGen, Inc., a private company developing Juvene™, the world's first modular, fluid-optic accommodating intraocular lens, has closed a $21 million Series A financing.  The financing was led by the corporate venture investment arm of HOYA Group and included participation from Relativity Healthcare Partners.  The financing includes an option to expand the financing commitment by an additional $5 million.

HOYA is a global technology and med-tech company, and a leading supplier of innovative high-tech and medical products. HOYA is active in the fields of healthcare and information technology providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses as well as key components for semiconductor devices, LCD panels and HDDs.

The Juvene™ accommodating intraocular lens is designed with the potential to permanently restore clear and continuous vision at all distances for patients with cataracts and presbyopia.  The lens provides accommodation by mimicking the eye's natural accommodation process to change shape and adjust focus, like the autofocus of a camera.  The lens is implanted using current surgical techniques used for traditional intraocular lenses.

Cataract surgeons have been waiting for an accommodative intraocular lens technology that is fully compatible with small incision cataract surgery and provides sufficient accommodation for presbyopic patients.